Computational immunogenomic approaches to predict response to cancer immunotherapies

Nature Reviews Clinical Oncology, Published online: 31 October 2023; doi:10.1038/s41571-023-00830-6Identifying patients who are likely to benefit from immune-checkpoint inhibitors remains one of the major challenges in immunotherapy. Cancer immunogenomics is an emerging field that bridges genomics and immunology. The authors of this Review provide an overview of the computational approaches currently available to analyse bulk tissue and single-cell sequencing data from cancer, stromal and immune cells.
Source: Nature Reviews Clinical Oncology - Category: Cancer & Oncology Authors: Source Type: research